Walpar Nutritions Ltd

NSE: WALPAR · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹26.10
Market cap: ₹24.51 Cr
Revenue (annual): ₹78.79 Cr
Net profit (annual): ₹3.00 Cr
P/E (TTM): 8.2×Sector 47.4×
Promoter holding: 68.82%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Results Correction 2 Management Change 2 Board Meeting Outcome 2 Annual General Meeting 2 Price Movement Clarification 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

29 Aug 2026 15:45 IST NSE

Board Meeting Outcome

Walpar Nutritions Board Meeting Outcome

Walpar Nutritions Limited's board appointed statutory auditors for five years, re-appointed four independent directors, and approved holding the 6th AGM on September 23, 2026.

Read the filing ↗

28 May 2026 18:58 IST NSE

Board Meeting Outcome

Walpar Nutritions Board Meeting Outcome

Walpar Nutritions Limited appointed M/s. Gaurav Bachani & Associates and M/s. Saumil J. Shah & Associates as auditors for twelve months. The board approved these changes during its May 2026 meeting.

Execution: 12 months

Read the filing ↗